Literature DB >> 1027153

Mutant alleles for hypoxanthine phosphoriboxyltransferase: codominant expression, complementation, and segregation in hybrid Chinese hamster cells.

L A Chasin, G Urlaub.   

Abstract

Chinese hamster ovary cell mutants resistant to the purine analogs 6-thioguanine or 8-azaguanine have been isolated following mutagenesis with ethyl methane sulfonate. The activities of hypoxanthine phosphoribosyltransferase (HPRT) in three such mutants have been found to exhibit an increased Km for the substrate 5-phosphoribosyl-1-pyrophosphate. The isoelectric point of the mutant enzyme activity has also changed in two mutants. Hybrid cells containing one mutant and one wild-type allele express both genes. Segregants that have lost only the wild-type allele can be selected on the basis of drug resistance. Two mutants exhibiting different alterations in HPRT activity can complement in a hybrid cell to yield a wild-type growth pattern and enzyme activity with intermediate electrophoretic and kinetic properties. The results suggest intracistronic complementation between structural gene mutants of HPRT.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1027153     DOI: 10.1007/BF01542725

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  30 in total

1.  Reexpression of HPRT activity following cell fusion with polyethylene glycol.

Authors:  B Bakay; M Graf; S Carey; E Nissinen; W L Nyhan
Journal:  Biochem Genet       Date:  1978-04       Impact factor: 1.890

2.  Sensitivity to low-dose/low-LET ionizing radiation in mammalian cells harboring mutations in succinate dehydrogenase subunit C is governed by mitochondria-derived reactive oxygen species.

Authors:  Nukhet Aykin-Burns; Benjamin G Slane; Annie T Y Liu; Kjerstin M Owens; Malinda S O'Malley; Brian J Smith; Frederick E Domann; Douglas R Spitz
Journal:  Radiat Res       Date:  2010-11-17       Impact factor: 2.841

3.  Genetic complementation among inherited deficiencies of methylmalonyl-CoA mutase activity: evidence for a new class of human cobalamin mutant.

Authors:  H F Willard; I S Mellman; L E Rosenberg
Journal:  Am J Hum Genet       Date:  1978-01       Impact factor: 11.025

4.  Positive genetic selection for gene disruption in mammalian cells by homologous recombination.

Authors:  J M Sedivy; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Cobalamin binding and cobalamin-dependent enzyme activity in normal and mutant human fibroblasts.

Authors:  I Mellman; H F Willard; L E Rosenberg
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

6.  Characterization of a mutator gene in Chinese hamster ovary cells.

Authors:  M Meuth; N L'Heureux-Huard; M Trudel
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  Hypoxanthine-guanine phosphoribosyltransferase deficiency in three brothers with gout: characterization of a variant, HPRTEdinburgh, having altered isoelectric point, increased thermal lability and normal levels of messenger RNA.

Authors:  F F Snyder; J E Joyce; T Carter-Edwards; R Joshi; H L Rylance; R C Wallace; G Nuki
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

8.  Evidence for DNA modification in the maintenance of X-chromosome inactivation of adult mouse tissues.

Authors:  V M Chapman; P G Kratzer; L D Siracusa; B A Quarantillo; R Evans; R M Liskay
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  Receptor-mediated endocytosis of low density lipoprotein: somatic cell mutants define multiple genes required for expression of surface-receptor activity.

Authors:  D M Kingsley; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

10.  Molecular analysis of ethyl methanesulfonate-induced reversion of a chromosomally integrated mutant shuttle vector gene in mammalian cells.

Authors:  J A Greenspan; F M Xu; R L Davidson
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.